Management ChangeJul 7, 2026, 04:33 PM
LifeStance Health Appoints 3 New Directors; Jeffrey Rhodes Resigns
AI Summary
LifeStance Health Group, Inc. announced that Jeffrey Rhodes resigned from its Board of Directors and all committees, effective July 2, 2026. His resignation was not due to any disagreement with the company. Concurrently, the Board appointed Thurman Justice, Lori Goltermann, and Safwan Shabab as new directors. Justice and Goltermann were appointed as Class II directors, while Shabab was appointed as a Class III director. Justice and Goltermann each received an initial award of 35,492 restricted stock units.
Key Highlights
- Jeffrey Rhodes resigned from LifeStance Health's Board and all committees on July 2, 2026.
- Thurman Justice, Lori Goltermann, and Safwan Shabab were appointed as new directors.
- Justice and Goltermann are Class II directors, serving until the 2029 annual meeting.
- Safwan Shabab is a Class III director, serving until the 2027 annual meeting.
- Justice and Goltermann each received 35,492 restricted stock units upon appointment.
- Justice joined the Audit and Quality and Compliance Committees.
- Goltermann joined the Compensation and Nominating and Governance Committees.
- Shabab joined the Nomination and Governance Committee.
Price Impact
More from LFST